Contributor Disclosures for Pseudoxanthoma Elasticum

Role Name Disclosure Details Author  L Frank Glass, MD, Chief of Dermatopathology, Associate Professor, Departments of Internal Medicine and Pathology, University of South Florida College of Medicine Nothing to disclose Details Coauthor  M Michelle (Shellie) Marks, MD, Clinical Research Fellow, Department of Dermatology, University of Alabama at Birmingham Nothing to disclose Details Coauthor  Daniel F Smith, MD, Consulting Staff, Bressinck, Gibson, Parker, Fangster, Smith, and Bruyneel Dermatology Nothing to disclose Details Coauthor  Neil A Fenske, MD, Director of Dermatology and Cutaneous Surgery, Professor, Departments of Internal Medicine and Pathology, University of South Florida College of Medicine Nothing to disclose Details Coauthor  Sujatha Tadicherla, MD, Staff Physician, Department of Dermatology and Cutaneous Surgery, University of South Florida College of Medicine Nothing to disclose Details Medical Editor  Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine Abbott Laboratories Actelion Amgen Astellas Basilea Boehringer-Ingelheim Briston-Myers Squibb Celtic Pharma Centocor Cephalon Chattem DermiPsor Doak DOV Forward Galderma Genentech Genzyme GlaxoSmithKline Graceway Helix BioMedix Isotechnika Ligand Medicis Neosil Novartis OMP Pepgen Pfizer PharmaDerm Roche Stiefel Teva UCB Warner Chilcott Details Pharmacy Editor  Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA none Details Managing Editor  Christen M Mowad, MD, Assistant Professor, Department of Dermatology, Geisinger Medical Center Nothing to disclose Details CME Editor  Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University Nothing to disclose Details Chief Editor  William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System elsevier Details Contributor Disclosure Contributor: Contributor Disclosure: L Frank Glass, Author  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: M Michelle (Shellie) Marks, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Daniel F Smith, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Neil A Fenske, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Sujatha Tadicherla, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Mark G Lebwohl  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Abbott Laboratories Honoraria Consulting   Actelion Honoraria Consulting   Amgen Honoraria Consulting   Astellas Honoraria Consulting   Basilea Honoraria Consulting   Boehringer-Ingelheim Honoraria Consulting   Briston-Myers Squibb Honoraria Consulting   Celtic Pharma Honoraria Other   Centocor Honoraria Consulting   Cephalon Honoraria Consulting   Chattem Honoraria Other   DermiPsor Honoraria Consulting   Doak Honoraria Other   DOV Honoraria Consulting   Forward Honoraria Consulting   Galderma Honoraria Consulting   Genentech Honoraria Consulting   Genzyme Honoraria Consulting   GlaxoSmithKline Honoraria Consulting   Graceway Honoraria Consulting   Helix BioMedix Honoraria Consulting   Isotechnika Honoraria Consulting   Ligand Honoraria Other   Medicis Honoraria Investigator   Neosil Honoraria Consulting   Novartis Honoraria Consulting   OMP Honoraria Other   Pepgen Honoraria Consulting   Pfizer Honoraria Consulting   PharmaDerm Honoraria Other   Roche Honoraria Consulting   Stiefel Honoraria Consulting   Teva Honoraria Consulting   UCB Honoraria Consulting   Warner Chilcott Honoraria Review panel membership   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Richard P Vinson  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** none None None   Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Christen M Mowad, Managing Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Catherine Quirk  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: William D James  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** elsevier Royalty Other   Off label or investigational use of medication